Among these surface molecules, ASGP-R, TfR, AF20 antigen, SSTR and LAPTM4B are potential therapeutic targets for HCC, but unsuitable for HCC diagnosis. This evidence concerns the gene ASGR1 and hepatocellular carcinoma.